Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25856843 | 0.74 | CNR1 (0.40) | CNR1CNR2MAPT | |
| SCHEMBL25856770 | 0.71 | CNR1 (0.40) | CNR1CNR2EPHX2MAPT | |
| SCHEMBL25856939 | 0.71 | CNR1 (0.40) | CNR1CNR2MAPT | |
| SCHEMBL25856972 | 0.71 | CNR1 (0.40) | CNR1CNR2MAPT | |
| SCHEMBL23558452 | 0.71 | CNR1 (0.39) | CNR1CNR2EPHX2MAPT | |
| SCHEMBL30735904 | 0.70 | ATM (0.48) | CNR1CNR2EPHX2MAPT | |
| SCHEMBL11387812 | 0.70 | ATM (0.48) | CNR1CNR2EPHX2MAPT | |
| SCHEMBL25856811 | 0.70 | CNR1 (0.37) | CNR1CNR2MAPT | |
| SCHEMBL25856660 | 0.70 | CNR1 (0.39) | CNR1CNR2EPHX2MAPT | |
| SCHEMBL2477617 | 0.70 | CYP19A1 (0.35) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234946-A1 | COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME | TREVENA, INC. | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234946-A1 | COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME | S1PR1, S1PR2, S1PR3 | CNR1 20/4885CNR2 38/4885EPHX2 1736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.